133 related articles for article (PubMed ID: 23967249)
1. The therapeutic effect on bone mineral formation from biomimetic zinc containing tricalcium phosphate (ZnTCP) in zinc-deficient osteoporotic mice.
Chou J; Hao J; Hatoyama H; Ben-Nissan B; Milthorpe B; Otsuka M
PLoS One; 2013; 8(8):e71821. PubMed ID: 23967249
[TBL] [Abstract][Full Text] [Related]
2. Effect of zinc-containing β-tricalcium phosphate nano particles injection on jawbone mineral density and mechanical strength of osteoporosis model rats.
Tokudome Y; Ito A; Otsuka M
Biol Pharm Bull; 2011; 34(8):1215-8. PubMed ID: 21804208
[TBL] [Abstract][Full Text] [Related]
3. Effect of particle size on zinc release from zinc containing tricalcium phosphate (ZnTCP) in Zn-deficient osteoporosis rats.
Otsuka M; Marunaka S; Matsuda Y; Ito A; Naito H; Ichinose N; Kokubo T; Nakamura T; Higuchi WI
Biomed Mater Eng; 2003; 13(2):103-13. PubMed ID: 12775901
[TBL] [Abstract][Full Text] [Related]
4. Effect of controlled zinc release on bone mineral density from injectable Zn-containing beta-tricalcium phosphate suspension in zinc-deficient diseased rats.
Otsuka M; Ohshita Y; Marunaka S; Matsuda Y; Ito A; Ichinose N; Otsuka K; Higuchi WI
J Biomed Mater Res A; 2004 Jun; 69(3):552-60. PubMed ID: 15127402
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the injectable calcium phosphate ceramics suspensions containing magnesium, zinc and fluoride on the bone mineral deficiency in ovariectomized rats.
Otsuka M; Oshinbe A; Legeros RZ; Tokudome Y; Ito A; Otsuka K; Higuchi WI
J Pharm Sci; 2008 Jan; 97(1):421-32. PubMed ID: 17879990
[TBL] [Abstract][Full Text] [Related]
6. Resorbability and solubility of zinc-containing tricalcium phosphate.
Ito A; Kawamura H; Miyakawa S; Layrolle P; Kanzaki N; Treboux G; Onuma K; Tsutsumi S
J Biomed Mater Res; 2002 May; 60(2):224-31. PubMed ID: 11857428
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of zinc-containing calcium phosphate suspension injection in thermal burn-rats.
Otsuka M; Shikamura M; Otsuka K; Sogo Y; Ito A
J Biomed Mater Res A; 2013 May; 101(5):1518-24. PubMed ID: 23281276
[TBL] [Abstract][Full Text] [Related]
8. Calcium level-responsive in-vitro zinc release from zinc containing tricalcium phosphate (ZnTCP).
Otsuka M; Marunaka S; Matsuda Y; Ito A; Layrolle P; Naito H; Ichinose N
J Biomed Mater Res; 2000 Dec; 52(4):819-24. PubMed ID: 11033565
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of the controlled release of simvastatin from β-TCP macrosphere in the treatment of OVX mice.
Chou J; Ito T; Otsuka M; Ben-Nissan B; Milthorpe B
J Tissue Eng Regen Med; 2016 Mar; 10(3):E195-203. PubMed ID: 23784984
[TBL] [Abstract][Full Text] [Related]
10. Possibility of alveolar bone promoting enhancement by using lipophilic and/or hydrophilic zinc related compounds in zinc-deficient osteoporosis rats.
Tokudome Y; Otsuka M
Biol Pharm Bull; 2012; 35(9):1496-501. PubMed ID: 22975500
[TBL] [Abstract][Full Text] [Related]
11. Bone regeneration of rat tibial defect by zinc-tricalcium phosphate (Zn-TCP) synthesized from porous Foraminifera carbonate macrospheres.
Chou J; Hao J; Kuroda S; Bishop D; Ben-Nissan B; Milthorpe B; Otsuka M
Mar Drugs; 2013 Dec; 11(12):5148-58. PubMed ID: 24351911
[TBL] [Abstract][Full Text] [Related]
12. Dissolution rate of zinc-containing beta-tricalcium phosphate ceramics.
Ito A; Senda K; Sogo Y; Oyane A; Yamazaki A; Legeros RZ
Biomed Mater; 2006 Sep; 1(3):134-9. PubMed ID: 18458394
[TBL] [Abstract][Full Text] [Related]
13. Intra-bone marrow injection of trace elements co-doped calcium phosphate microparticles for the treatment of osteoporotic rat.
Yang X; Xu S; Chen X; He D; Ke X; Zhang L; Yang G; Liu A; Mou X; Xia W; Gou Z
J Biomed Mater Res A; 2017 May; 105(5):1422-1432. PubMed ID: 28233417
[TBL] [Abstract][Full Text] [Related]
14. Stimulatory effect of zinc-releasing calcium phosphate implant on bone formation in rabbit femora.
Kawamura H; Ito A; Miyakawa S; Layrolle P; Ojima K; Ichinose N; Tateishi T
J Biomed Mater Res; 2000 May; 50(2):184-90. PubMed ID: 10679683
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with parathyroid hormone (1-34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model.
Tao ZS; Tu KK; Huang ZL; Zhou Q; Sun T; Xu HM; Zhou YL; Lv YX; Cui W; Yang L
Med Biol Eng Comput; 2016 Sep; 54(9):1353-62. PubMed ID: 26429350
[TBL] [Abstract][Full Text] [Related]
16. Long-term therapeutic effect of novel calcium phosphate-based compounds injected in ovariectomized rats.
Tokudome Y; Otsuka M; Ito A; LeGeros RZ
J Biomed Mater Res B Appl Biomater; 2009 Jul; 90(1):229-37. PubMed ID: 19145625
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts.
Yamada Y; Ito A; Kojima H; Sakane M; Miyakawa S; Uemura T; LeGeros RZ
J Biomed Mater Res A; 2008 Feb; 84(2):344-52. PubMed ID: 17618520
[TBL] [Abstract][Full Text] [Related]
18. Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats.
Tao ZS; Zhou WS; Xu HG; Yang M
Biomed Pharmacother; 2020 Dec; 132():110911. PubMed ID: 33125972
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Biocomposite Screws on Bone Regeneration in a Rat Osteoporosis Model.
Jeong JH; Jin ES; Kim JY; Lee B; Min J; Jeon SR; Lee M; Choi KH
World Neurosurg; 2017 Oct; 106():964-972. PubMed ID: 28736352
[TBL] [Abstract][Full Text] [Related]
20. Gradient coatings of strontium hydroxyapatite/zinc β-tricalcium phosphate as a tool to modulate osteoblast/osteoclast response.
Boanini E; Torricelli P; Sima F; Axente E; Fini M; Mihailescu IN; Bigi A
J Inorg Biochem; 2018 Jun; 183():1-8. PubMed ID: 29525694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
